Details

Primerjava treh metod za dokazovanje respiratornega sincicijskega virusa : diplomska naloga
ID Bevc, Tjaša (Author), ID Petrovec, Miroslav (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://www.ffa.uni-lj.si/fileadmin/datoteke/Knjiznica/diplome/2010/Bevc_Tjasa_dipl_nal_2010.pdf This link opens in a new window

Language:Slovenian
Keywords:respiratorni sincicijski virus, reagenti, kronična pljučna bolezen, testi, diagnostika, izolacija nukleinskih kislin
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FFA - Faculty of Pharmacy
Place of publishing:Ljubljana
Publisher:[T. Bevc]
Year:2010
Number of pages:IV, 36 f.
PID:20.500.12556/RUL-71046 This link opens in a new window
UDC:616-074
COBISS.SI-ID:2848113 This link opens in a new window
Publication date in RUL:10.07.2015
Views:2276
Downloads:265
Metadata:XML DC-XML DC-RDF
:
BEVC, Tjaša, 2010, Primerjava treh metod za dokazovanje respiratornega sincicijskega virusa : diplomska naloga [online]. Bachelor’s thesis. Ljubljana : T. Bevc. [Accessed 30 March 2025]. Retrieved from: http://www.ffa.uni-lj.si/fileadmin/datoteke/Knjiznica/diplome/2010/Bevc_Tjasa_dipl_nal_2010.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Comparison of three methods for detection of respiratory syncytial virus

Similar documents

Similar works from RUL:
  1. Systematic review and meta-analysis of observational studies evaluating treatment outcomes in patients with metastatic non-small-cell lung cancer on first-line immune checkpoint inhibitors therapy
  2. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  3. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  4. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
  5. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Similar works from other Slovenian collections:
  1. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  4. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  5. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Back